Your browser doesn't support javascript.
loading
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.
Sieber, Markus; Tesch, Hans; Pfistner, Beate; Rueffer, Ulrich; Lathan, Bernd; Brosteanu, Oana; Paulus, Ursula; Koch, Tina; Pfreundschuh, Michael; Loeffler, Markus; Engert, Andreas; Josting, Andreas; Wolf, Jürgen; Hasenclever, Dirk; Franklin, Jeremy; Duehmke, Eckhart; Georgii, Axel; Schalk, Klaus-Peter; Kirchner, Hartmut; Doelken, Gottfried; Munker, Reinhold; Koch, Peter; Herrmann, Richard; Greil, Richard; Anselmo, Anna Paola; Diehl, Volker.
Afiliação
  • Sieber M; German Hodgkin's Lymphoma Study Group, Cologne, Germany. markus.sieber@medizin.uni-koeln.de
J Clin Oncol ; 20(2): 476-84, 2002 Jan 15.
Article em En | MEDLINE | ID: mdl-11786577
Assuntos
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2002 Tipo de documento: Article
Buscar no Google
Imprimir
XML
PubMed Links

Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials / Risk_factors_studies Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2002 Tipo de documento: Article